e-learning
resources
London 2016
Tuesday, 06.09.2016
Asthma management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Olaf Schmidt (Koblenz, Germany), Olaf Schmidt, Frank Kanniess, Petra Oepen, Birgit Langer-Brauburger
Source:
International Congress 2016 – Asthma management
Session:
Asthma management
Session type:
Thematic Poster
Number:
4118
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Olaf Schmidt (Koblenz, Germany), Olaf Schmidt, Frank Kanniess, Petra Oepen, Birgit Langer-Brauburger. Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study. Eur Respir J 2016; 48: Suppl. 60, 4118
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Impact of adherence to fluticasone propionate/salmeterol combination (FSC) therapy on the outcomes of patients with asthma: A population based study
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Asthma control in asthmatics treated with extrafine or non-extrafine ICS/LABA combinations in real life setting
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Efficacy and safety of fluticasone propionate/formoterol in paediatric patients with asthma
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Outcomes with omalizumab in Indian patients with allergic (IgE-mediated) asthma: Results at 16 and 28 weeks
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Maintenance and reliever combination budesonide/formoterol therapy in asthma patients at risk of severe exacerbations: A randomised controlled trial
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
Real-life effectiveness of budesonide/formoterol for the management of asthma and COPD
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016
Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Correlation between meteo-climatological factors and asthma exacerbation among children: A prospective study
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016
Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept